HomeBVS • NASDAQ
add
Bioventus Inc
Previous close
$11.24
Day range
$11.31 - $11.86
Year range
$3.36 - $14.37
Market cap
959.25M USD
Avg Volume
482.29K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 138.96M | 15.04% |
Operating expense | 86.91M | 15.65% |
Net income | -4.82M | 33.94% |
Net profit margin | -3.47 | 42.64% |
Earnings per share | 0.06 | 20.00% |
EBITDA | 18.91M | 7.92% |
Effective tax rate | -12.19% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 43.07M | 60.56% |
Total assets | 769.49M | -5.13% |
Total liabilities | 582.66M | -0.34% |
Total equity | 186.83M | — |
Shares outstanding | 65.37M | — |
Price to book | 4.93 | — |
Return on assets | 2.13% | — |
Return on capital | 2.80% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -4.82M | 33.94% |
Cash from operations | 10.32M | 224.06% |
Cash from investing | -64.00K | 96.86% |
Cash from financing | 362.00K | -95.60% |
Net change in cash | 11.08M | 532.47% |
Free cash flow | 13.68M | 251.06% |
About
Founded
2011
Website
Employees
1,030